Sun Pharma News

Sun Pharma reported a two-fold jump in net profit to Rs 894.15 crore in the quarter ended March 2021 from Rs 399.84 crore in the same quarter last year

Sun Pharmaceutical shares rose as much as 3.51% to hit an intraday high of Rs 703.40 after it signed an agreement with Eli Lilly to make baricitinib.

List of Stocks in Focus Today: Wipro has bagged a multi-year contract to develop new features, capabilities and interfaces for Verifone's Cloud Services offerings, enabling seamless and flexible transaction processing for the company

Tata Consultancy Services, Wipro, Tata Steel, Sun Pharma and JSW Steel, closing between 3.17 per cent and 7.55 per cent higher, were the top Nifty gainers.

Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.

IICT Hyderabad: The deal is for patents related to certain compounds with potential therapeutic activity across multiple indications in Sun Pharma's specialty focus areas, the Mumbai-based pharmaceuticals company said on Wednesday.

Companies like Coal India, ONGC, Sun Pharma, Reliance Capital and Suzlon Energy are also expected to announce their quarterly results.

Share Market News: Choice Broking recommends selling Sun Pharma shares in the range of Rs 429 and up to Rs 432 for downside target of Rs 412 with stop loss at Rs 438.

In terms of quarterly results, companies like Abbott India, Bharat Heavy Electricals, Emami, GAIL, Interglobe Aviation, Punjab National Bank, SpiceJet, Sun Pharma, GMR Infra, M&M and Power Finance Corp are expected to announce their fourth quarter (Q4) earnings results in the coming week.

JSW Steel, Dr Reddy's Labs, Sun Pharma, Hero MotoCorp and Tata Steel were among the top Nifty losers.

The U.S. generics industry is facing rapidly changing market dynamics, Sun Pharma said

Major players that supported the recovery were Axis Bank, Sun Pharma, Tata Motors, Wipro, HDFC Ltd, Asian Paints, NTPC and ICICI Bank.

Biosintez is a Russian pharmaceutical company focusing on the hospital segment with annual revenues of approximately US$ 52 million for 2015.

Sun Pharmaceutical Industries completed the divestment of its seven prescription brands in India to RPG Life Sciences.

Industrialist Mukesh Ambani was named India's richest person for a ninth year in a row with a sharp increase in networth to $22.7 billion, while Sun Pharma's Dilip Shanghvi was ranked a distant second with a wealth of $16.9 billion.

Sun Pharma reported a two-fold jump in net profit to Rs 894.15 crore in the quarter ended March 2021 from Rs 399.84 crore in the same quarter last year

Sun Pharmaceutical shares rose as much as 3.51% to hit an intraday high of Rs 703.40 after it signed an agreement with Eli Lilly to make baricitinib.

List of Stocks in Focus Today: Wipro has bagged a multi-year contract to develop new features, capabilities and interfaces for Verifone's Cloud Services offerings, enabling seamless and flexible transaction processing for the company

Tata Consultancy Services, Wipro, Tata Steel, Sun Pharma and JSW Steel, closing between 3.17 per cent and 7.55 per cent higher, were the top Nifty gainers.

Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.

IICT Hyderabad: The deal is for patents related to certain compounds with potential therapeutic activity across multiple indications in Sun Pharma's specialty focus areas, the Mumbai-based pharmaceuticals company said on Wednesday.

Companies like Coal India, ONGC, Sun Pharma, Reliance Capital and Suzlon Energy are also expected to announce their quarterly results.

Share Market News: Choice Broking recommends selling Sun Pharma shares in the range of Rs 429 and up to Rs 432 for downside target of Rs 412 with stop loss at Rs 438.

In terms of quarterly results, companies like Abbott India, Bharat Heavy Electricals, Emami, GAIL, Interglobe Aviation, Punjab National Bank, SpiceJet, Sun Pharma, GMR Infra, M&M and Power Finance Corp are expected to announce their fourth quarter (Q4) earnings results in the coming week.

JSW Steel, Dr Reddy's Labs, Sun Pharma, Hero MotoCorp and Tata Steel were among the top Nifty losers.

The U.S. generics industry is facing rapidly changing market dynamics, Sun Pharma said

Major players that supported the recovery were Axis Bank, Sun Pharma, Tata Motors, Wipro, HDFC Ltd, Asian Paints, NTPC and ICICI Bank.

Biosintez is a Russian pharmaceutical company focusing on the hospital segment with annual revenues of approximately US$ 52 million for 2015.

Sun Pharmaceutical Industries completed the divestment of its seven prescription brands in India to RPG Life Sciences.

Industrialist Mukesh Ambani was named India's richest person for a ninth year in a row with a sharp increase in networth to $22.7 billion, while Sun Pharma's Dilip Shanghvi was ranked a distant second with a wealth of $16.9 billion.